Multiple Sclerosis Trial, Recruiting NCT06394310 Sponsor: University of Kansas Medical Center Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06394310
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 64 years old
  • You have been diagnosed with Multiple Sclerosis using standard medical diagnostic guidelines (called the McDonald Criteria)
  • You experience muscle stiffness or tightness (spasticity) in your lower legs
  • Your level of disability, as measured by a specific MS walking and mobility scale (PDDS), is rated at 5 or below, meaning you are able to walk with some assistance at most

Who may not be able to join:

  • You have difficulty communicating with the study team
  • You have a fear of needles
  • You have severe varicose veins
  • You have an active implanted medical device (such as a pacemaker)
  • You are currently pregnant
  • You have or have had cancer within the past year
  • You have a known or suspected infection at or near the area where needles would be used
  • You have a condition where your ankle is permanently fixed in a pointed-foot position (confirm with trial site)
  • You have a recent broken bone or joint dislocation in either of your lower legs or feet
  • You have a blood clot in a deep vein or poor circulation in your legs
  • You have inflammation of a vein with clotting, or an active bone infection in your lower legs or feet
  • Your medications have been changed in the past three months, including any medicines used to treat muscle stiffness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 913-588-3715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Kansas Medical Center
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
2 July 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Spasticity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov